Here are four cancer-related partnerships formed since Jan. 14.
Oncology
The University of Chicago Medicine Comprehensive Cancer Center appointed Mary Dolan, PhD, its deputy director, the center said Jan. 19.
The University of Texas MD Anderson Cancer Center in Houston and Planegg, Germany-based Eisbach Bio GmbH announced a research collaboration on Jan. 19 dedicated to discovering and developing precision oncology drugs that target synthetic lethal engines.
Recent cancer research has focused on nationwide death rates from the disease since 2019, lung-cancer assessment risks using blood samples and more.
Edison, N.J.-based Hackensack Meridian Health and Paterson, N.J.-based St. Joseph's Health announced a clinical affiliation Jan. 14 to bring patients expanded oncologic services.
Advertisement
Overall cancer deaths in the U.S. have declined 32 percent since 2019, according to a report published Jan. 12 in CA: A Cancer Journal for Clinicians.
Edison, N.J.-based Hackensack Meridian Health and Paterson, N.J.-based St. Joseph's Health announced a clinical affiliation Jan. 14 to bring patients expanded oncologic services.
Tampa, Fla.-based Moffitt Cancer Center named Elsa Flores, PhD, the associate center director of Basic Science, the organization said Jan. 11.
The surgery department at Gainesville, Fla.-based UF Health has successfully performed its first cytoreductive surgery and heated intraperitoneal chemotherapy to treat abdominal cancer.
These five oncologists joined new practices or received new appointments over the last few weeks.